The main aim of the study is to investigate whether orally administered oxytocin (24IU) can modulate neural and behavioral responses to positive and negative valence stimuli during basal (emotional scenes) and higher order (facial stimuli) emotional processing.
Age range
17 Years – 32 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Effect of oral oxytocin administration of oxytocin on neural responses to positive and negative valence emotional faces, as assessed by task fMRI
Timeframe: 45-90 minutes after treatment
Effect of oral oxytocin administration on neural responses to positive and negative valence scenes, as assessed by fMRI
Timeframe: 45-90 minutes after treatment
Effect of oral oxytocin administration on behavioral ratings of face emotion and scene stimuli
Timeframe: 45-115 minutes after treatment
Change in blood oxytocin concentrations following oral administration of oxytocin
Timeframe: 30 minutes before treatment and 30 minutes after treatment